The DACH region encompasses Germany, Austria, and Switzerland. Credit: Tom Korcak via Shutterstock. Amid tightening EU ...

At the 15mg dose, participants showed a sustained average weight loss of 22.9% during the three-year treatment. Credit: SB ...

Despite this success, investors were unimpressed with the topline data, with Syndax’s stock dropping by 25.6%, from $21.78 ...

Medical advances and better knowledge of health have contributed to increased life expectancy and a growing elderly ...

They say lightning rarely strikes twice but Kezar Life Sciences has suffered its second clinical blow in as many months.

Lyophilization plays a crucial role in successful biologic molecule development, but what is lyophilization – and how can it ...

Longboard has commenced the Phase III DEEp OCEAN Study of bexicaserin for treating seizures linked to DEEs in two years and ...

The company plans to discontinue the study after the combination therapy failed to meet the primary endpoint in the Phase III ...

At two upcoming events on rare disease clinical trials and data management, experts will dissect the latest trends and ...

The trial enrolled 145 individuals with baseline characteristics, such as gender and distribution of PNs, representative of the global adult NF1 patient population. Credit: TimeImage ...

Arch Biopartners has dosed the first patient in Canada in its Phase II clinical trial of LSALT peptide (Metablok) for acute ...

AbbVie’s stock price fell over 12% after emraclidine failed to meet its primary endpoints in the company’s Phase II ...